Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Chimeric antigen receptor (CAR) and application thereof

A chimeric antigen receptor and antibody technology, applied in the direction of hybrid peptide, receptor/cell surface antigen/cell surface determinant, anti-receptor/cell surface antigen/cell surface determinant immunoglobulin, etc., can solve Issues such as increased labor and cost

Active Publication Date: 2017-06-06
广东昭泰细胞生物科技有限公司
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Recently, studies have found that the ratio of CD4 and CD8 T cells in CAR T cells has a great influence on the anti-tumor activity of CAR T cells, and the ratio of CD4 T cells in CAR T cells is positively correlated with the therapeutic effect of CAR T cells. To obtain a large number of CD4 CAR T cells, it is necessary to first sort out CD4 and CD8 CAR T cells during in vitro culture, and then expand CD4 and CD8 CAR T cells through different cytokine combinations, which undoubtedly increases the huge labor and cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chimeric antigen receptor (CAR) and application thereof
  • Chimeric antigen receptor (CAR) and application thereof
  • Chimeric antigen receptor (CAR) and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0081] Example 1: Construction of Chimeric Antigen Receptor

[0082] (1) Synthesize 19-H.28z, Meso-H.28z, PSCA-H.28z containing IgG4-CH3 hinge region and 19.28z, Meso.28z, PSCA.28z CAR molecular sequence without hinge region through whole gene synthesis , the C-terminus of the synthetic gene contains a restriction endonuclease PmeI restriction site, and the N-terminus contains a restriction endonuclease SpeI restriction site. The full-length gene map of the CAR molecule is as follows: figure 1 shown;

[0083] The nucleic acid sequence of the IgG4-CH3 hinge region is shown in SEQ ID NO.1:

[0084] Ggcggaggtagctctggcggtggatccggcgggcagccccgagaaccacaggtgtacaccctgcccccatcccgggatgagctgaccaagaaccaggtcagcctgacctgcctggtcaaaggcttctatcccagcgacatcgccgtggagtgggagagcaatgggcagccggagaacaactacaagaccacgcctcccgtgctggactccgacggctccttcttcctctacagcaagctcaccgtggacaagagcaggtggcagcaggggaacgtcttctcatgctccgtgatgcatgaggctctgcacaaccactacacgcagaagagcctctccctgtctccgggtaaa.

[0085] The nucleic acid sequen...

Embodiment 2

[0099] Example 2: Lentiviral packaging

[0100] When the cells cover 80-90% of the bottom of the 100mm culture dish, perform lentiviral packaging:

[0101] (1) 2 hours before virus packaging, the medium was replaced with DMEM containing 1% fetal bovine serum, 5mL / 100mm per culture dish;

[0102] (2) The packaging plasmids to be added to each 100mm culture dish of 293T cells are as follows:

[0103] Reagent dose pWPXLd-CAR-eGFP plasmid 4.5μg pMD2.G helper plasmid 1.5μg psPAX2 6μg

[0104] Add the plasmid to 500 μL opti-MEM medium and mix well;

[0105] Among them, pWPXLd-CAR-eGFP plasmids include: pwpxld-19.28z-eGFP, pwpxld-19-H.28z-eGFP, pwpxld-Meso.28z-eGFP, pwpxld-Meso-H.28z-eGFP, pwpxld-PSCA.28z -eGFP, pwpxld-PSCA-H.28z-eGFP;

[0106] (3) Add 36 μg PEI to another 500 μL opti-MEM medium, mix well, and let stand at room temperature for 5 minutes;

[0107] (4) Mix the plasmid with PEI, mix well by pipetting, and let stand at room tempe...

Embodiment 3

[0112] Example 3: Construction of CAR T cells

[0113] (1) Separation and purification of human T cells: Peripheral blood mononuclear cells (PBMC) were separated from whole blood by Ficoll (GE Company) density gradient centrifugation; ) to sort out T cells; T cells were activated for 72 hours using a T cell activation kit (Miltenyi);

[0114] (2) Lentiviral transfection of T cells: 72h after T cell activation, demagnetize the beads, resuspend the cells in 1640 medium containing 10% fetal bovine serum, 300IU / mLIL2, add the virus supernatant prepared in Example 2, every 10 6 Add 1mL virus supernatant to cells, polybrene 8μg / mL, at 37°C, 5% CO 2 After culturing in the incubator for 12 hours, resuspend with fresh medium containing 300IU / mL IL-2, every 10 6 Add 1 mL of culture medium to each cell.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of tumor cellular immunotherapy, in particular to a chimeric antigen receptor (CAR) and application thereof. The CAR comprises a hinge region, and the hinge region is IgG4-CH3. The IgG4-CH3 hinge region is introduced into a CAR molecular structure, so that the amplification efficiency of CAR T cells can be specifically increased in an in-vitro culture process, the amplification of CD4+CAR T cells is mainly promoted, CD4 cells and CD8 T cells do not need to be cultured in a separated way, the process is completed in a mixing system, and the amplification efficiency of the CD4+CAR T cells is increased.

Description

technical field [0001] The present invention relates to the field of tumor cell immunotherapy, in particular to a chimeric antigen receptor and its application, specifically a method for expanding CAR T cells by using a chimeric antigen receptor, a new CD4+CAR T cell expansion method method of increasing. Background technique [0002] In the past five years, adoptive immunotherapy such as chimeric antigen receptor T cells (Chimeric antigen receptor, CAR) has rapidly transformed from the basic scientific research stage to clinical trials, and has demonstrated strong tumor killing effects in clinical trials. CAR is a recombinant receptor that can specifically target tumor antigens, and generally consists of a single chain antibody variable region gene fragment (Singlechain fragment variable, scFv), hinge region (Hinge, H), transmembrane region, costimulatory molecule, CD3ζ chain and other components. [0003] So far, the fourth generation of CAR molecules has been developed....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N7/01C12N5/10
CPCC07K14/7051C07K14/70521C07K16/00C07K16/28C07K16/2803C07K2319/02C07K2319/03C12N5/0636C12N7/00C12N2740/15043
Inventor 不公告发明人
Owner 广东昭泰细胞生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com